Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Expression of Escherichia coli virulence usher protein attenuates wild-type Salmonella.

Yang X, Suo Z, Thornburg T, Holderness K, Cao L, Lim T, Walters N, Kellerman L, Loetterle L, Avci R, Pascual DW.

Virulence. 2012 Jan-Feb;3(1):29-42. doi: 10.4161/viru.3.1.18447. Epub 2012 Jan 1.

2.

Coming of AGE: facile generation of attenuated vaccine strains through heterologous gene expression.

Goller CC, Seed PC.

Virulence. 2012 Jan-Feb;3(1):12-4. doi: 10.4161/viru.3.1.19087. Epub 2012 Jan 1.

4.

Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.

Lasaro MO, Luiz WB, Sbrogio-Almeida ME, Ferreira LC.

Vaccine. 2005 Mar 31;23(19):2430-8.

PMID:
15752829
5.

Attenuating gene expression (AGE) for vaccine development.

Pascual DW, Suo Z, Cao L, Avci R, Yang X.

Virulence. 2013 Jul 1;4(5):384-90. doi: 10.4161/viru.24886. Epub 2013 May 7. Review.

6.

Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response.

Pascual DW, Hone DM, Hall S, van Ginkel FW, Yamamoto M, Walters N, Fujihashi K, Powell RJ, Wu S, Vancott JL, Kiyono H, McGhee JR.

Infect Immun. 1999 Dec;67(12):6249-56.

8.

Maternal vaccination with a fimbrial tip adhesin and passive protection of neonatal mice against lethal human enterotoxigenic Escherichia coli challenge.

Luiz WB, Rodrigues JF, Crabb JH, Savarino SJ, Ferreira LC.

Infect Immun. 2015 Dec;83(12):4555-64. doi: 10.1128/IAI.00858-15. Epub 2015 Sep 14.

9.

Serum antibodies protect against intraperitoneal challenge with enterotoxigenic Escherichia coli.

Yang X, Thornburg T, Holderness K, Suo Z, Cao L, Lim T, Avci R, Pascual DW.

J Biomed Biotechnol. 2011;2011:632396. doi: 10.1155/2011/632396. Epub 2011 Oct 9.

10.

TTSS2-deficient hha mutant of Salmonella Typhimurium exhibits significant systemic attenuation in immunocompromised hosts.

Vishwakarma V, Pati NB, Ray S, Das S, Suar M.

Virulence. 2014 Feb 15;5(2):311-20. doi: 10.4161/viru.27605. Epub 2014 Jan 8.

11.

Phosphate groups of lipid A are essential for Salmonella enterica serovar Typhimurium virulence and affect innate and adaptive immunity.

Kong Q, Six DA, Liu Q, Gu L, Wang S, Alamuri P, Raetz CR, Curtiss R 3rd.

Infect Immun. 2012 Sep;80(9):3215-24. doi: 10.1128/IAI.00123-12. Epub 2012 Jul 2.

12.

Construction and expression of immunogenic hybrid enterotoxigenic Escherichia coli CFA/I and CS2 colonization fimbriae for use in vaccines.

Tobias J, Svennerholm AM, Holmgren J, Lebens M.

Appl Microbiol Biotechnol. 2010 Jul;87(4):1355-65. doi: 10.1007/s00253-010-2577-4. Epub 2010 Apr 20.

PMID:
20405124
15.

Expression of periplasmic chaperones in Salmonella Typhimurium reduces its viability in vivo.

Mertensotto MJ, Drees JJ, Augustin LB, Schottel JL, Saltzman DA.

Curr Microbiol. 2015 Mar;70(3):433-5. doi: 10.1007/s00284-014-0739-9. Epub 2014 Nov 29.

PMID:
25432864
16.

Immunization against the colonization factor antigen I of enterotoxigenic Escherichia coli by administration of a bivalent Salmonella typhimurium aroA strain.

Guillobel HC, Luna MG, Camacho EF, Almeida DF, Ferreira LC.

Braz J Med Biol Res. 1998 Apr;31(4):545-54.

PMID:
9698808
19.

Over-expression of major colonization factors of enterotoxigenic Escherichia coli, alone or together, on non-toxigenic E. coli bacteria.

Tobias J, Holmgren J, Hellman M, Nygren E, Lebens M, Svennerholm AM.

Vaccine. 2010 Oct 8;28(43):6977-84. doi: 10.1016/j.vaccine.2010.08.047. Epub 2010 Aug 20.

PMID:
20728524
20.

Insertion of a 59 amino acid peptide in Salmonella Typhimurium membrane results in loss of virulence in mice.

Porta A, Morello S, Granata I, Iannone R, Maresca B.

FEBS J. 2014 Nov;281(22):5043-53. doi: 10.1111/febs.13042. Epub 2014 Oct 4.

Supplemental Content

Support Center